M2 Human Genomics in Biotherapies, Health and Disease (HuGeInBio)

Students will learn to formulate hypotheses, design and carry out experimental projects, and generate validated scientific data. They will also develop the ability to monitor scientific advances and independently synthesize the state of the art on a given research topic. 

Students will be trained to use new technological tools, communicate scientific data and concepts to both experts and non-specialists, justify methodological choices and interpretations, and critically analyze scientific information from articles or conferences in English. 

Students will develop autonomy, teamwork, and time management skills to meet deadlines. They will also learn to collaborate with external partners—scientific or non-scientific, national or international—across various professional contexts.

This training will provide you with a strong foundation in modern genomics and its applications in research and healthcare. You will develop: 

1. Expertise in structural and functional genomics techniques, with a focus on single-cell analysis and the study of spatial and temporal cellular heterogeneity in complex biological samples—essential for choosing the right approach to specific scientific questions. 
2. Hands-on skills in implementing multi-omics strategies from an experimental point of view, enabling you to work confidently in a laboratory setting. 
3. A clear understanding of how genomic data impacts patient diagnosis, care, and treatment, including the use of large-scale screening tools (such as CRISPR/shRNA or compound libraries) for therapeutic discovery. 
4. The ability to collaborate effectively with bioinformaticians, guiding data processing workflows and independently performing downstream functional analysis to extract and apply relevant findings to your research projects. 
5. Awareness of the ethical and legal challenges surrounding precision genomics and the responsible use of genomic data. 
6. An introduction to entrepreneurship in human genomics, helping you explore the intersection between science, innovation, and business development. 
7. Insight into the broader research ecosystem, both nationally and internationally, through seminars and courses offered in collaboration with public and private partners—including those from the EUGLOH European University Alliance.

Throughout the program, students will benefit from a cutting-edge research environment in genomics and post-genomics. This Master’s program is developed in synergy with Genopole and the GenoTher biocluster, and in collaboration with the Paris Saclay Cancer Cluster.